Shares of Glenmark Pharmaceuticals in intra-day trade on April 30, 2020 rallied a whopping 9% as it became the first company to receive the Drug Controller General of India (DCGI) approval for conducting trials of tablets for treatment against Covid 19 patients.
Glenmark Pharma Rallies 9% On DCGI Approval For Covid 19 Trial
On both the stock exchanges it rallied to a high of Rs. 359 per share.
The company by itself developed the active pharmaceutical ingredients (API) as well as the formulations for the product and filed for the approval by the DGCI and received the regulators nod for conducting trial of the tablet on mild to moderate patients of the virus.
Favipiravir antiviral tablet has shown results against influenza viruses and has been approved in Japan for treating novel influenza virus infections, it added. Last at 2:06 pm, the stock quoted higher by 4.16% or Rs. 13.7 at Rs. 343.40. The stock's 52-week high price is Rs. 653.60 per share.
GoodReturns.in
Notifications
Settings
Clear Notifications
No New Notifications
Notifications
Use the toggle to switch on notifications
Block for 8 hours
Block for 12 hours
Block for 24 hours
Don't block
To start receiving timely alerts, as shown below click on the Green “lock” icon next to the address bar
Click it and Unblock the Notifications
Close X
Close X
To Start receiving timely alerts please follow the below steps:
Click on the Menu icon of the browser, it opens up a list of options.
Click on the “Options ”, it opens up the settings page,
Here click on the “Privacy & Security” options listed on the left hand side of the page.
Scroll down the page to the “Permission” section .
Here click on the “Settings” tab of the Notification option.
A pop up will open with all listed sites, select the option “ALLOW“, for the respective site under the status head to allow the notification.
Once the changes is done, click on the “Save Changes” option to save the changes.
Click it and Unblock the Notifications
Sign in with Google